These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Premalignant lesions of the larynx: pathological prognostic factors. Riera Velasco JR; Suárez Nieto C; Pedrero de Bustos C; Alvarez Marcos C J Otolaryngol; 1987 Dec; 16(6):367-70. PubMed ID: 3694745 [TBL] [Abstract][Full Text] [Related]
24. Retinoid X receptor overexpression desensitizes laryngeal epithelium to carcinogenic effects associated with epidermal growth factor receptor upregulation. Kourelis K; Vandoros G; Kourelis T; Goumas P; Sotiropoulou-Bonikou G J Otolaryngol Head Neck Surg; 2009 Apr; 38(2):233-9. PubMed ID: 19442374 [TBL] [Abstract][Full Text] [Related]
25. Karyometry by automated image analysis. Application to precancerous lesions. Rigaut JP; Reith A; el Kebir FZ Pathol Res Pract; 1984 Nov; 179(2):216-9. PubMed ID: 6522331 [TBL] [Abstract][Full Text] [Related]
26. Microsatellite instability as an indicator of malignant progression in laryngeal premalignancy. Sardi I; Franchi A; De Campora L; Passali GC; Gallo O Head Neck; 2006 Aug; 28(8):730-9. PubMed ID: 16721747 [TBL] [Abstract][Full Text] [Related]
27. Genetic model of transformation and neoplastic progression in laryngeal epithelium. Marcos CÁ; Alonso-Guervós M; Prado NR; Gimeno TS; Iglesias FD; Hermsen M; Llorente JL Head Neck; 2011 Feb; 33(2):216-24. PubMed ID: 20629083 [TBL] [Abstract][Full Text] [Related]
28. Precancerous lesions of the larynx. Friedmann I Can J Otolaryngol; 1974; 3(4):528-32. PubMed ID: 4429885 [No Abstract] [Full Text] [Related]
29. Immunohistochemical expression of metallothionein in benign premalignant and malignant epithelium of the larynx: correlation with p53 and proliferative cell nuclear antigen. Ioachim E; Assimakopoulos D; Peschos D; Zissi A; Skevas A; Agnantis NJ Pathol Res Pract; 1999; 195(12):809-14. PubMed ID: 10631715 [TBL] [Abstract][Full Text] [Related]
30. Mutational profiling can identify laryngeal dysplasia at risk of progression to invasive carcinoma. Manterola L; Aguirre P; Larrea E; Arestín M; Gaafar A; Elorriaga K; Goicoechea I; Armesto M; Fernández-Mercado M; Zabalza I; López-Duque JC; Larruskain E; Sistiaga JA; Landa M; Zabala A; Santaolalla F; Municio JA; Ispizua Á; García-Pedrero JM; Rodrigo JP; Lawrie CH Sci Rep; 2018 Apr; 8(1):6613. PubMed ID: 29700339 [TBL] [Abstract][Full Text] [Related]
31. Correlation of DNA content of laryngeal epithelial lesions to degree of malignancy. Ispizua A; Baroja A; de la Hoz C J Clin Oncol; 1994 Aug; 12(8):1600-6. PubMed ID: 8040672 [TBL] [Abstract][Full Text] [Related]
32. Coordinated upregulation of COX-2 and NF-kappaB is a steady feature of laryngeal carcinogenesis. Kourelis K; Sotiropoulou-Bonikou G; Vandoros G; Repanti M; Varakis I; Goumas P ORL J Otorhinolaryngol Relat Spec; 2007; 69(3):181-9. PubMed ID: 17264535 [TBL] [Abstract][Full Text] [Related]
33. Biologic correlates of a biochemoprevention trial in advanced upper aerodigestive tract premalignant lesions. Papadimitrakopoulou VA; Liu DD; Mao L; Shin DM; El-Naggar A; Ibarguen H; Lee JJ; Hong WK; Hittelman WN Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1605-10. PubMed ID: 12496051 [TBL] [Abstract][Full Text] [Related]
34. Human telomerase reverse transcriptase expression and its clinical significance in laryngeal squamous cell carcinoma. Li YR; Wu JM; Wang L; Huang X; Shi J; Hu LH Acta Otolaryngol; 2005 Apr; 125(4):409-14. PubMed ID: 15823813 [TBL] [Abstract][Full Text] [Related]
35. [The expressions and significance of CK2 in normal laryngeal mucosa, laryngeal precancerosis and laryngeal squamous cell carcinoma]. Wu L; Liu B Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Sep; 21(18):825-7, 830. PubMed ID: 18062282 [TBL] [Abstract][Full Text] [Related]
36. Premalignant laryngeal lesions, carcinoma in situ, superficial carcinoma--definition and management. Miller AH Can J Otolaryngol; 1974; 3(4):573-5. PubMed ID: 4429894 [No Abstract] [Full Text] [Related]
37. [Detection of human papillomavirus gene sequences in laryngeal tumors and premalignant changes by polymerase chain reaction]. Czeglédy J; Major T; Juhász A; Répássy G; Gergely L Orv Hetil; 1997 Jul; 138(30):1891-5. PubMed ID: 9289687 [TBL] [Abstract][Full Text] [Related]
38. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features. Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413 [TBL] [Abstract][Full Text] [Related]
39. Laryngeal keratosis and atypia. Fechner RE Can J Otolaryngol; 1974; 3(4):516-21. PubMed ID: 4429882 [No Abstract] [Full Text] [Related]
40. [DNA content in laryngeal keratosis, laryngeal cancer and normal laryngeal epithelium]. Zhi T Zhonghua Er Bi Yan Hou Ke Za Zhi; 1989; 24(4):236-8, 255. PubMed ID: 2486078 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]